Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00483145 |
Recruitment Status :
Completed
First Posted : June 6, 2007
Last Update Posted : June 3, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Acne Vulgaris and Rosacea | Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single |
Official Title: | Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea |
Study Start Date : | November 2006 |
Actual Study Completion Date : | November 2007 |

Arm | Intervention/treatment |
---|---|
Active Comparator: 1
Long-pulsed dye laser (Candela)
|
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser |
Active Comparator: 2
Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
|
Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate) |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- Inflammatory acne and rosacea
- Skin types I-IV
Exclusion Criteria:
- Patients younger than 18 years
- Skin types V and VI
- Topical and systemic conventional acne treatments

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00483145
Denmark | |
Bispebjerg Hospital | |
Copenhagen NV, Denmark, 2400 |
Principal Investigator: | Merete Hædersdal | Bispebjerg Hospital |
Responsible Party: | Merete Hædersdal, Bispebjerg Hospital |
ClinicalTrials.gov Identifier: | NCT00483145 |
Other Study ID Numbers: |
KF-01-328309 |
First Posted: | June 6, 2007 Key Record Dates |
Last Update Posted: | June 3, 2008 |
Last Verified: | June 2008 |
Acne Vulgaris Rosacea Acneiform Eruptions Skin Diseases Sebaceous Gland Diseases |
Methyl 5-aminolevulinate Aminolevulinic Acid Photosensitizing Agents Dermatologic Agents |